Exact Mass: 458.2488854
Exact Mass Matches: 458.2488854
Found 284 metabolites which its exact mass value is equals to given mass value 458.2488854
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Astemizole
C28H31FN4O (458.24817679999995)
Astemizole is a long-acting, non-sedating second generation antihistamine used in the treatment of allergy symptoms. It was withdrawn from market by the manufacturer in 1999 due to the potential to cause arrhythmias at high doses, especially when when taken with CYP inhibitors or grapefruit juice. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 5-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 4-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 4-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes
1-Lyso-2-arachidonoyl-phosphatidate
LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
LysoPA(20:4(5Z,8Z,11Z,14Z)/0:0)
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is also known as LPA(20:4(5Z,8Z,11Z,14Z)/0:0) or 1-Arachidonoyl lpa. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0)
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of eicosatetraenoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
3-Prenylrubranine
Sophoranochromene
Sophoradochromene
(5S)--5,6,7,7a,7b,12b-hexahydro-3,4,5,11,12b-pentamethyl-10-[(3E)-pent-3-en-1-yl]-furo[3,2:6,7]naphthol[1,8:4,5,6]pyrano[3,2-b]benzofuran-9-ol
(2E)-1-(3,4-dihydro-5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-[2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]prop-2-en-1-one|tokinochromane C
9-hydroxy-gamma-geraniol-1-O-(6-isovaleryl-3-acetyl-beta-D-glucopyranoside)
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitoleate
C28H39ClO3 (458.25875740000004)
(3S,4R)-4-([(1S,2R,4aR,5R,8aS)-decahydro-2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethylnaphthalen-1-yl]methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid K
pierisformotoxin D|rel-(3beta,6beta,7alpha,14R)-3,5,7,10,14,15,16-heptahydroxygrayanotoxan-6-yl propanoate
9-Acetoxy-gamma-geraniol-1-O-<3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-[3-(2-methylbutanoyl)]-beta-D-glucopyranoside
9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-[6-acetyl-3-(2-methylbutanoyl)]-beta-D-glucopyranoside
lespeflorin A3
A monohydroxyflavanone that is flavanone substituted with a hydroxy group at position 7, prenyl groups at positions 6 and 8 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 3 and 4. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
Ala Ile Gln Gln
Ala Leu Gln Gln
Ala Gln Ile Gln
Ala Gln Leu Gln
Ala Gln Gln Ile
Ala Gln Gln Leu
Phe Pro Pro Val
Phe Pro Val Pro
Phe Val Pro Pro
Ile Ala Gln Gln
Ile Met Pro Val
Ile Met Val Pro
Ile Asn Asn Val
Ile Asn Val Asn
Ile Pro Met Val
Ile Pro Val Met
Ile Gln Ala Gln
Ile Gln Gln Ala
Ile Val Met Pro
Ile Val Asn Asn
Ile Val Pro Met
Lys Asn Pro Thr
Lys Asn Thr Pro
Lys Pro Asn Thr
Lys Pro Gln Ser
Lys Pro Ser Gln
Lys Pro Thr Asn
Lys Gln Pro Ser
Lys Gln Ser Pro
Lys Ser Pro Gln
Lys Ser Gln Pro
Lys Thr Asn Pro
Lys Thr Pro Asn
Leu Ala Gln Gln
Leu Met Pro Val
Leu Met Val Pro
Leu Asn Asn Val
Leu Asn Val Asn
Leu Pro Met Val
Leu Pro Val Met
Leu Gln Ala Gln
Leu Gln Gln Ala
Leu Val Met Pro
Leu Val Asn Asn
Leu Val Pro Met
Met Ile Pro Val
Met Ile Val Pro
Met Leu Pro Val
Met Leu Val Pro
Met Pro Ile Val
Met Pro Leu Val
Met Pro Val Ile
Met Pro Val Leu
Met Val Ile Pro
Met Val Leu Pro
Met Val Pro Ile
Met Val Pro Leu
Asn Ile Asn Val
Asn Ile Val Asn
Asn Lys Pro Thr
Asn Lys Thr Pro
Asn Leu Asn Val
Asn Leu Val Asn
Asn Asn Ile Val
Asn Asn Leu Val
Asn Asn Val Ile
Asn Asn Val Leu
Asn Pro Lys Thr
Asn Pro Thr Lys
Asn Gln Val Val
Asn Thr Lys Pro
Asn Thr Pro Lys
Asn Val Ile Asn
Asn Val Leu Asn
Asn Val Asn Ile
Asn Val Asn Leu
Asn Val Gln Val
Asn Val Val Gln
Pro Phe Pro Val
Pro Phe Val Pro
Pro Ile Met Val
Pro Ile Val Met
Pro Lys Asn Thr
Pro Lys Gln Ser
Pro Lys Ser Gln
Pro Lys Thr Asn
Pro Leu Met Val
Pro Leu Val Met
Pro Met Ile Val
Pro Met Leu Val
Pro Met Val Ile
Pro Met Val Leu
Pro Asn Lys Thr
Pro Asn Thr Lys
Pro Pro Phe Val
Pro Pro Val Phe
Pro Gln Lys Ser
Pro Gln Ser Lys
Pro Ser Lys Gln
Pro Ser Gln Lys
Pro Thr Lys Asn
Pro Thr Asn Lys
Pro Val Phe Pro
Pro Val Ile Met
Pro Val Leu Met
Pro Val Met Ile
Pro Val Met Leu
Pro Val Pro Phe
Gln Ala Ile Gln
Gln Ala Leu Gln
Gln Ala Gln Ile
Gln Ala Gln Leu
Gln Ile Ala Gln
Gln Ile Gln Ala
Gln Lys Pro Ser
Gln Lys Ser Pro
Gln Leu Ala Gln
Gln Leu Gln Ala
Gln Asn Val Val
Gln Pro Lys Ser
Gln Pro Ser Lys
Gln Gln Ala Ile
Gln Gln Ala Leu
Gln Gln Ile Ala
Gln Gln Leu Ala
Gln Ser Lys Pro
Gln Ser Pro Lys
Gln Val Asn Val
Gln Val Val Asn
Ser Lys Pro Gln
Ser Lys Gln Pro
Ser Pro Lys Gln
Ser Pro Gln Lys
Ser Gln Lys Pro
Ser Gln Pro Lys
Thr Lys Asn Pro
Thr Lys Pro Asn
Thr Asn Lys Pro
Thr Asn Pro Lys
Thr Pro Lys Asn
Thr Pro Asn Lys
Val Phe Pro Pro
Val Ile Met Pro
Val Ile Asn Asn
Val Ile Pro Met
Val Leu Met Pro
Val Leu Asn Asn
Val Leu Pro Met
Val Met Ile Pro
Val Met Leu Pro
Val Met Pro Ile
Val Met Pro Leu
Val Asn Ile Asn
Val Asn Leu Asn
Val Asn Asn Ile
Val Asn Asn Leu
Val Asn Gln Val
Val Asn Val Gln
Val Pro Phe Pro
Val Pro Ile Met
Val Pro Leu Met
Val Pro Met Ile
Val Pro Met Leu
Val Pro Pro Phe
Val Gln Asn Val
Val Gln Val Asn
Val Val Asn Gln
Val Val Gln Asn
LysoPA(20:4/0:0)
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
1-oleoyl-sn-glycero-3-phosphate sodium salt
C21H40NaO7P (458.24092200000007)
1-(4-Phenylboronic acid pinacol ester)-1,2,2-triphenylethene
C32H31BO2 (458.24169759999995)
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 4-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 4-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes Constituent of ginger (Zingiber officinale) rhizomes. [6]-Gingerdiol 4-glucoside is found in herbs and spices.
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 5-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes Constituent of ginger (Zingiber officinale) rhizomes. [6]-Gingerdiol 5-glucoside is found in herbs and spices.
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioate
C30H34O4-2 (458.24569640000004)
[(1S,2R,3R,4S,5R)-5-azaniumyl-2-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]azanium
C17H38N4O10+4 (458.25878079999995)
Homoplatensimide A
A polycyclic cage compound isolated from Streptomyces platensis.
3-[[cyclopentyl-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]amino]methyl]-7-methyl-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
cyclobutyl-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(1S)-1-(hydroxymethyl)-7-methoxy-2-(2-methoxy-1-oxoethyl)-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-methoxy-1-oxoethyl)-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
astemizole
C28H31FN4O (458.24817679999995)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
1-arachidonoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-O-acyl group is specified as arachidonoyl.
Ribostamycin(4+)
C17H38N4O10 (458.25878079999995)
An organic cation obtained by protonation of the four amino groups of ribostamycin; major species at pH 7.3.
4,4-diapolycopenedioate
A dicarboxylic acid dianion derived from 4,4-diapolycopen-4,4-dioic acid. Major structure at pH 7.3,
2-Arachidonoyl-sn-glycero-3-phosphate
A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as arachidonoyl.
BIX 02565
C26H30N6O2 (458.24301199999996)
BIX 02565 is a potent ribosomal S6 kinase 2 (RSK2) inhibitor with IC50 of 1.1 nM.